The high-normal blood pressure (also known as prehypertension) is a clinical condition characterized by an increased cardiovascular risk as well as by the presence of target organ damage. This include an increased left ventricular mass, an endothelial dysfunction and an early renal functional and structural damage. Whether this is the case also for alterations of retinal vessels network, which are frequently detectable in established hypertension, is still largey undefined. The present paper, after discussing the main characteristics of the high-normal blood pressure state, will review the different approaches used throughout the years for assessing retinal microcirculatory network. Data collected by our group in subjects with high normal blood pressure will be also discussed, showing that arterial venular ratio values are reduced in this individuals with high-normal blood pressure and more so in established hypertension. These data indicate that retinal microvascular alterations 1) are of early appearance in the clinical course of hypertension and 2) are of frequent detection in the high-normal blood pressure state. The possible hemodynamic and non-hemodynamic mechanisms resposible for these structural alteations of the retinal microcirculation will be also discussed.
Keywords: Hypertension, high-normal blood pressure, retinal microcirculation, organ damage, arterovenular ratio, sympathetic nervous system, prehypertension, ventricular mass, non-hemodynamic mechanisms, organ damage
Plasma Potassium Levels in Healthy Prehypertension Subjects and the Role of A High Potassium Drink
Current Hypertension Reviews Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology Cardiovascular Disease in Masked Hypertension: Clinical Implications
Current Hypertension Reviews Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization) Pharmacologic Treatment for Prehypertension: To Treat or Not to Treat?
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Ambulatory Blood Pressure Monitoring in Prehypertensive Subjects
Cardiovascular & Hematological Disorders-Drug Targets Endothelial Changes in Individuals with Prehypertension
Current Hypertension Reviews Management of Prehypertension: Current Status and Future Strategies
Current Hypertension Reviews Endothelial Progenitor Cells in Prehypertension
Current Pharmaceutical Design Is Hypertension an Inflammatory Process?
Current Pharmaceutical Design